Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 478 articles:
HTML format



Single Articles


    January 2021
  1. AHMAD N, Baharom M, Aizuddin AN, Ramli R, et al
    Sex-related differences in smear-positive pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: Prevalence and associated factors.
    PLoS One. 2021;16:e0245304.
    PubMed     Abstract available


  2. HASSUNA NA, El Feky M, Hussein AARM, Mahmoud MA, et al
    Interleukin-18 and interferon-gamma single nucleotide polymorphisms in Egyptian patients with tuberculosis.
    PLoS One. 2021;16:e0244949.
    PubMed     Abstract available


  3. MARIN AV, Rastogi N, Couvin D, Mape V, et al
    First approach to the population structure of Mycobacterium tuberculosis complex in the indigenous population in Puerto Narino-Amazonas, Colombia.
    PLoS One. 2021;16:e0245084.
    PubMed     Abstract available


  4. KIM J, Park BG, Lim DH, Jang WS, et al
    Development and evaluation of a multiplex loop-mediated isothermal amplification (LAMP) assay for differentiation of Mycobacterium tuberculosis and non-tuberculosis mycobacterium in clinical samples.
    PLoS One. 2021;16:e0244753.
    PubMed     Abstract available


  5. SHANKAR S U, Kumar AMV, Venkateshmurthy NS, Nair D, et al
    Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
    PLoS One. 2021;16:e0244785.
    PubMed     Abstract available


  6. ASEMAHAGN MA, Alene GD, Yimer SA
    Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia.
    PLoS One. 2021;16:e0245378.
    PubMed     Abstract available


  7. KHALIQ A, Ravindran R, Afzal S, Jena PK, et al
    Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
    PLoS One. 2021;16:e0245534.
    PubMed     Abstract available


  8. THAYER MB, Parish T
    Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0239353.
    PubMed     Abstract available


  9. OLADIMEJI O, Adepoju V, Anyiam FE, San JE, et al
    Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
    PLoS One. 2021;16:e0244581.
    PubMed     Abstract available


  10. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    PubMed     Abstract available


  11. CHUNG HS, Bae S, Kim I, Ahn HY, et al
    Unexpected exposure to Mycobacterium tuberculosis during bronchoscopy using radial probe endobronchial ultrasound.
    PLoS One. 2021;16:e0246371.
    PubMed     Abstract available


  12. DAGNE B, Desta K, Fekade R, Amare M, et al
    The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia.
    PLoS One. 2021;16:e0245687.
    PubMed     Abstract available


  13. LOPEZ K, Arriaga MB, Aliaga JG, Barreda NN, et al
    Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru.
    PLoS One. 2021;16:e0243184.
    PubMed     Abstract available


  14. SORSA A, Kaso M
    Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0242205.
    PubMed     Abstract available


  15. XIA T, Chen J, Rui J, Li J, et al
    What affected Chinese parents' decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey.
    PLoS One. 2021;16:e0245691.
    PubMed     Abstract available


  16. GAUTAM N, Karki RR, Khanam R
    Knowledge on tuberculosis and utilization of DOTS service by tuberculosis patients in Lalitpur District, Nepal.
    PLoS One. 2021;16:e0245686.
    PubMed     Abstract available


  17. LIM RK, Semitala FC, Atuhumuza E, Sabiti L, et al
    Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.
    PLoS One. 2021;16:e0246113.
    PubMed     Abstract available


  18. SHIN HJ, Chang JS, Kim MS, Koh BG, et al
    Hypersensitivity reactions to multiple anti-tuberculosis drugs.
    PLoS One. 2021;16:e0246291.
    PubMed     Abstract available


  19. KHAN MS, Rego S, Rajal JB, Bond V, et al
    Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
    PLoS One. 2021;16:e0244936.
    PubMed     Abstract available


  20. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0245458.
    PubMed     Abstract available


  21. SOEROTO AY, Pratiwi C, Santoso P, Lestari BW, et al
    Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    PLoS One. 2021;16:e0246284.
    PubMed     Abstract available


  22. YUEN CM, Millones AK, Puma D, Jimenez J, et al
    Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru.
    PLoS One. 2021;16:e0247411.
    PubMed     Abstract available


  23. KASSA GM, Merid MW, Muluneh AG, Wolde HF, et al
    Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    PLoS One. 2021;16:e0246938.
    PubMed     Abstract available


  24. NAZNEEN A, Tarannum S, Chowdhury KIA, Islam MT, et al
    Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals.
    PLoS One. 2021;16:e0246923.
    PubMed     Abstract available


  25. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.
    PLoS One. 2021;16:e0246993.
    PubMed     Abstract available


  26. ISLAM MN, Khan MK, Khan MFR, Kostoulas P, et al
    Risk factors and true prevalence of bovine tuberculosis in Bangladesh.
    PLoS One. 2021;16:e0247838.
    PubMed     Abstract available


  27. HENNEBERG M, Holloway-Kew K, Lucas T
    Human major infections: Tuberculosis, treponematoses, leprosy-A paleopathological perspective of their evolution.
    PLoS One. 2021;16:e0243687.
    PubMed     Abstract available


  28. FANG Y, Ma Y, Lu Q, Sun J, et al
    An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019.
    PLoS One. 2021;16:e0247564.
    PubMed     Abstract available


  29. LAZARUS G, Tjoa K, Iskandar AWB, Louisa M, et al
    The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248017.
    PubMed     Abstract available


  30. LANDSMAN D, Abdelbasit A, Wang C, Guerzhoy M, et al
    Cohort profile: St. Michael's Hospital Tuberculosis Database (SMH-TB), a retrospective cohort of electronic health record data and variables extracted using natural language processing.
    PLoS One. 2021;16:e0247872.
    PubMed     Abstract available


  31. TOMAZ APO, Raboni SM, Kussen GMB, da Silva Nogueira K, et al
    The Xpert(R) MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: Benefits and experiences over 2 years in different clinical contexts.
    PLoS One. 2021;16:e0247185.
    PubMed     Abstract available


  32. BIERMANN O, Kluppelberg R, Lonnroth K, Viney K, et al
    'A double-edged sword': Perceived benefits and harms of active case-finding for people with presumptive tuberculosis and communities-A qualitative study based on expert interviews.
    PLoS One. 2021;16:e0247568.
    PubMed     Abstract available


  33. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  34. HOHLFELD ASJ, Mathebula L, Pienaar ED, Abrams A, et al
    Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis.
    PLoS One. 2021;16:e0248621.
    PubMed     Abstract available


  35. OHENE SA, Bonsu F, Adusi-Poku Y, Dzata F, et al
    Case finding of tuberculosis among mining communities in Ghana.
    PLoS One. 2021;16:e0248718.
    PubMed     Abstract available


  36. SMITH GC, Budgey R
    Simulating the next steps in badger control for bovine tuberculosis in England.
    PLoS One. 2021;16:e0248426.
    PubMed     Abstract available


  37. ANDARGIE A, Molla A, Tadese F, Zewdie S, et al
    Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248687.
    PubMed     Abstract available


  38. CHARLES M, Richard M, Reichler MR, Koama JB, et al
    Treatment success for patients with tuberculosis receiving care in areas severely affected by Hurricane Matthew - Haiti, 2016.
    PLoS One. 2021;16:e0247750.
    PubMed     Abstract available


  39. AMEKE S, Asare P, Aboagye SY, Otchere ID, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
    PLoS One. 2021;16:e0238898.
    PubMed     Abstract available


  40. ROSENFELD G, Gabrielian A, Wang Q, Gu J, et al
    Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases.
    PLoS One. 2021;16:e0247906.
    PubMed     Abstract available


  41. ABDU M, Ali Y, Anteneh S, Yesuf M, et al
    Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
    PLoS One. 2021;16:e0248490.
    PubMed     Abstract available


  42. HUDDART S, Singh M, Jha N, Benedetti A, et al
    Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
    PLoS One. 2021;16:e0249225.
    PubMed     Abstract available


  43. HAN WM, Mahikul W, Pouplin T, Lawpoolsri S, et al
    Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
    PLoS One. 2021;16:e0248846.
    PubMed     Abstract available


  44. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    PubMed     Abstract available


  45. HEFFERNAN C, Paulsen C, Asadi L, Egedahl ML, et al
    Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study.
    PLoS One. 2021;16:e0248493.
    PubMed     Abstract available


  46. WOLDESEMAYAT EM, Azeze Z
    Treatment outcome of tuberculosis at Dilla Referral Hospital, Gedeo Zone, southern Ethiopia: A retrospective study.
    PLoS One. 2021;16:e0249369.
    PubMed     Abstract available


  47. MIRZAZADEH A, Kahn JG, Haddad MB, Hill AN, et al
    State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    PLoS One. 2021;16:e0249012.
    PubMed     Abstract available


  48. STEFANESCU S, Cocos R, Turcu-Stiolica A, Mahler B, et al
    Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania.
    PLoS One. 2021;16:e0249301.
    PubMed     Abstract available


  49. XU F, Tian L, Li Y, Zhang X, et al
    High prevalence of extrapulmonary tuberculosis in dairy farms: Evidence for possible gastrointestinal transmission.
    PLoS One. 2021;16:e0249341.
    PubMed     Abstract available


  50. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Correction: Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0249545.
    PubMed     Abstract available


  51. THIEL BA, Worodria W, Nalukwago S, Nsereko M, et al
    Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249477.
    PubMed     Abstract available


  52. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    PubMed     Abstract available


  53. HEWAGE S, Somasundaram N, Ratnasamy V, Ranathunga I, et al
    Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.
    PLoS One. 2021;16:e0249787.
    PubMed     Abstract available


  54. MEKKAOUI L, Hallin M, Mouchet F, Payen MC, et al
    Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
    PLoS One. 2021;16:e0249734.
    PubMed     Abstract available


  55. GWITIRA I, Karumazondo N, Shekede MD, Sandy C, et al
    Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.
    PLoS One. 2021;16:e0249523.
    PubMed     Abstract available


  56. JAKHAR S, Sakamuri R, Vu D, Dighe P, et al
    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
    PLoS One. 2021;16:e0243337.
    PubMed     Abstract available


  57. SPEKKER O, Kis L, Deak A, Makai E, et al
    An unusual case of childhood osteoarticular tuberculosis from the Arpadian Age cemetery of Gyorszentivan-Revhegyi tag (Gyor-Moson-Sopron county, Hungary).
    PLoS One. 2021;16:e0249939.
    PubMed     Abstract available


  58. CHAVES-TORRES NM, Fadul S, Patino J, Netto E, et al
    Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0249565.
    PubMed     Abstract available


  59. MCCALLAN L, Brooks C, Barry C, Couzens C, et al
    Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland.
    PLoS One. 2021;16:e0245655.
    PubMed     Abstract available


  60. RAISANEN PE, Haanpera M, Soini H, Ruutu P, et al
    Transmission of tuberculosis between foreign-born and Finnish-born populations in Finland, 2014-2017.
    PLoS One. 2021;16:e0250674.
    PubMed     Abstract available


  61. CARTER BB, Zhang Y, Zou H, Zhang C, et al
    Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia.
    PLoS One. 2021;16:e0249474.
    PubMed     Abstract available


  62. SAKTIAWATI AMI, Triyana K, Wahyuningtias SD, Dwihardiani B, et al
    eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249689.
    PubMed     Abstract available


  63. OLIVEIRA O, Gaio R, Correia-Neves M, Rito T, et al
    Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    PLoS One. 2021;16:e0250028.
    PubMed     Abstract available


  64. COLY S, Garrido M, Abrial D, Yao AF, et al
    Bayesian hierarchical models for disease mapping applied to contagious pathologies.
    PLoS One. 2021;16:e0222898.
    PubMed     Abstract available


  65. MINJA LT, Hella J, Mbwambo J, Nyandindi C, et al
    High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania.
    PLoS One. 2021;16:e0250038.
    PubMed     Abstract available


  66. HO LJ, Yang HY, Chung CH, Chang WC, et al
    Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study.
    PLoS One. 2021;16:e0250531.
    PubMed     Abstract available


  67. NGUYEN LH, Tran PTM, Dam TA, Forse RJ, et al
    Assessing private provider perceptions and the acceptability of video observed treatment technology for tuberculosis treatment adherence in three cities across Viet Nam.
    PLoS One. 2021;16:e0250644.
    PubMed     Abstract available


  68. BIGIO J, Kohli M, Klinton JS, MacLean E, et al
    Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review.
    PLoS One. 2021;16:e0251236.
    PubMed     Abstract available


  69. WOLDEYOHANNES D, Tekalegn Y, Sahiledengle B, Assefa T, et al
    Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    PLoS One. 2021;16:e0250804.
    PubMed     Abstract available


  70. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0250933.
    PubMed     Abstract available


  71. JARSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2021;16:e0250586.
    PubMed     Abstract available


  72. NERLICH AG, Kirchhoff SM, Panzer S, Lehn C, et al
    Chronic active non-lethal human-type tuberculosis in a high royal Bavarian officer of Napoleonic times-a mummy study.
    PLoS One. 2021;16:e0249955.
    PubMed     Abstract available


  73. LEE HN, Kim JI, Kim YH
    Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0250616.
    PubMed     Abstract available


  74. JADHAV R, Gallardo-Macias R, Kumar G, Daher SS, et al
    Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249841.
    PubMed     Abstract available


  75. KABUGO J, Namutebi J, Mujuni D, Nsawotebba A, et al
    Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
    PLoS One. 2021;16:e0251691.
    PubMed     Abstract available


  76. ROBSKY KO, Isooba D, Nakasolya O, Mukiibi J, et al
    Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda.
    PLoS One. 2021;16:e0251806.
    PubMed     Abstract available


  77. FOSTER N, Cunnama L, McCarthy K, Ramma L, et al
    Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    PLoS One. 2021;16:e0251547.
    PubMed     Abstract available


  78. ARAYA BT, Ali KE, Geleta DA, Tekele SG, et al
    Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens.
    PLoS One. 2021;16:e0251602.
    PubMed     Abstract available


  79. KABIR S, Parash MTH, Emran NA, Hossain ABMT, et al
    Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    PLoS One. 2021;16:e0251858.
    PubMed     Abstract available


  80. HIRSCH-MOVERMAN Y, Howard AA, Mantell JE, Lebelo L, et al
    Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study.
    PLoS One. 2021;16:e0248516.
    PubMed     Abstract available


  81. WOOD RC, Andama A, Hermansky G, Burkot S, et al
    Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.
    PLoS One. 2021;16:e0251422.
    PubMed     Abstract available


  82. BERRA TZ, Gomes D, Ramos ACV, Alves YM, et al
    Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil.
    PLoS One. 2021;16:e0252375.
    PubMed     Abstract available


  83. VASANTHA M, Muniyandi M, Ponnuraja C, Srinivasan R, et al
    Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients.
    PLoS One. 2021;16:e0252205.
    PubMed     Abstract available


  84. SHIFERAW MB, Sinishaw MA, Amare D, Alem G, et al
    Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia.
    PLoS One. 2021;16:e0253177.
    PubMed     Abstract available


  85. YANG H, Yang Y, Hu ZD, Xia L, et al
    High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    PLoS One. 2021;16:e0253159.
    PubMed     Abstract available


  86. SINGPANOMCHAI N, Akeda Y, Tomono K, Tamaru A, et al
    Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
    PLoS One. 2021;16:e0253235.
    PubMed     Abstract available


  87. SYLVERKEN AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, et al
    The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    PLoS One. 2021;16:e0252819.
    PubMed     Abstract available


  88. ARCENCIO RA, Berra TZ, Terena NFM, Rocha MP, et al
    Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    PLoS One. 2021;16:e0252712.
    PubMed     Abstract available


  89. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available



  90. Retraction: The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases.
    PLoS One. 2021;16:e0253035.
    PubMed    


  91. THOMAS BE, Thiruvengadam K, Vedhachalam C, A S, et al
    Prevalence of pulmonary tuberculosis among the tribal populations in India.
    PLoS One. 2021;16:e0251519.
    PubMed     Abstract available


  92. QADER GQ, Seddiq MK, Rashidi KM, Manzoor L, et al
    Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study.
    PLoS One. 2021;16:e0252307.
    PubMed     Abstract available


  93. MUSAKWA NO, Bor J, Nattey C, Lonnermark E, et al
    Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa.
    PLoS One. 2021;16:e0245427.
    PubMed     Abstract available


  94. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed     Abstract available


  95. LIANG T, Chen J, Xu G, Zhang Z, et al
    Immune status changing helps diagnose osteoarticular tuberculosis.
    PLoS One. 2021;16:e0252875.
    PubMed     Abstract available


  96. OSMAN M, Meehan SA, von Delft A, Du Preez K, et al
    Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2021;16:e0252084.
    PubMed     Abstract available


  97. PAN SW, Su WJ, Chan YJ, Chuang FY, et al
    Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection.
    PLoS One. 2021;16:e0253879.
    PubMed     Abstract available


  98. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253525.
    PubMed     Abstract available


  99. YU G, Shen Y, Ye B, Shi Y, et al
    Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253658.
    PubMed     Abstract available


  100. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed     Abstract available


  101. CHAI J, Wang Q, Qin B, Wang S, et al
    Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.
    PLoS One. 2021;16:e0253339.
    PubMed     Abstract available


  102. MOHIDEM NA, Osman M, Hashim Z, Muharam FM, et al
    Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.
    PLoS One. 2021;16:e0252146.
    PubMed     Abstract available


  103. LAZZARI TK, Cavalheiro E, Coutinho SE, da Silva LF, et al
    Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
    PLoS One. 2021;16:e0254198.
    PubMed     Abstract available


  104. OUDGHIRI A, Momen G, Aainouss A, Laglaoui A, et al
    Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco.
    PLoS One. 2021;16:e0253826.
    PubMed     Abstract available


  105. ALMAW G, Conlan AJK, Ameni G, Gumi B, et al
    The variable prevalence of bovine tuberculosis among dairy herds in Central Ethiopia provides opportunities for targeted intervention.
    PLoS One. 2021;16:e0254091.
    PubMed     Abstract available


  106. OBSA MS, Daga WB, Wosene NG, Gebremedhin TD, et al
    Treatment seeking delay and associated factors among tuberculosis patients attending health facility in Ethiopia from 2000 to 2020: A systematic review and meta analysis.
    PLoS One. 2021;16:e0253746.
    PubMed     Abstract available


  107. DAWIT Z, Abebe S, Dessu S, Mesele M, et al
    Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    PLoS One. 2021;16:e0253449.
    PubMed     Abstract available


  108. ALEMU A, Bitew ZW, Worku T, Gamtesa DF, et al
    Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253848.
    PubMed     Abstract available


  109. CRECELIUS EM, Lustik MB, Horseman TS, Jones MU, et al
    The prevalence of M. tuberculosis among acid fast bacilli cultures from military health system and veterans affairs beneficiaries in Hawaii and the Pacific Islands from 2002 to 2019.
    PLoS One. 2021;16:e0254312.
    PubMed     Abstract available


  110. CUONG NK, Ngoc NB, Hoa NB, Dat VQ, et al
    GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0253961.
    PubMed     Abstract available


  111. TADOKERA R, Huo S, Theron G, Timire C, et al
    Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
    PLoS One. 2021;16:e0254204.
    PubMed     Abstract available


  112. TANG J, Huang Y, Cai Z, Ma Y, et al
    Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0254571.
    PubMed     Abstract available


  113. MAOKOLA WM, Ngowi BJ, Mahande MJ, Todd J, et al
    Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
    PLoS One. 2021;16:e0254082.
    PubMed     Abstract available


  114. SHAYO FK, Shayo SC
    Readiness of healthcare facilities with tuberculosis services to manage diabetes mellitus in Tanzania: A nationwide analysis for evidence-informed policy-making in high burden settings.
    PLoS One. 2021;16:e0254349.
    PubMed     Abstract available


  115. BOAH M, Kpordoxah MR, Adokiya MN
    Self-reported gender differentials in the knowledge of tuberculosis transmission and curative possibility using national representative data in Ghana.
    PLoS One. 2021;16:e0254499.
    PubMed     Abstract available


  116. SAMUELS THA, Wyss R, Ongarello S, Moore DAJ, et al
    Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    PLoS One. 2021;16:e0254002.
    PubMed     Abstract available


  117. TAYE H, Alemu K, Mihret A, Ayalew S, et al
    Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
    PLoS One. 2021;16:e0253480.
    PubMed     Abstract available


  118. SALCEDO J, Rosales M, Kim JS, Nuno D, et al
    Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study.
    PLoS One. 2021;16:e0254950.
    PubMed     Abstract available


  119. ARJA A, Godana W, Hassen H, Bogale B, et al
    Patient delay and associated factors among tuberculosis patients in Gamo zone public health facilities, Southern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2021;16:e0255327.
    PubMed     Abstract available


  120. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    PubMed     Abstract available


  121. CONNELLY JT, Andama A, Grant BD, Ball A, et al
    Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
    PLoS One. 2021;16:e0254156.
    PubMed     Abstract available


  122. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    Novel health system strategies for tuberculin skin testing at primary care clinics: Performance assessment and health economic evaluation.
    PLoS One. 2021;16:e0246523.
    PubMed     Abstract available


  123. IM C, Kim Y
    Spatial pattern of tuberculosis (TB) and related socio-environmental factors in South Korea, 2008-2016.
    PLoS One. 2021;16:e0255727.
    PubMed     Abstract available


  124. ISLAM SS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Correction: Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2021;16:e0256042.
    PubMed     Abstract available


  125. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    PubMed     Abstract available


  126. ALISJAHBANA B, Koesoemadinata RC, Hadisoemarto PF, Lestari BW, et al
    Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding.
    PLoS One. 2021;16:e0256043.
    PubMed     Abstract available


  127. DHAKULKAR S, Das M, Sutar N, Oswal V, et al
    Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
    PLoS One. 2021;16:e0246639.
    PubMed     Abstract available


  128. FOREMAN HC, Frank A, Stedman TT
    Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors.
    PLoS One. 2021;16:e0256079.
    PubMed     Abstract available


  129. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0256717.
    PubMed     Abstract available


  130. KHAN IA, Nayak B, Markandey M, Bajaj A, et al
    Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    PLoS One. 2021;16:e0256098.
    PubMed     Abstract available


  131. NATHAVITHARANA RR, van der Westhuizen A, van der Westhuizen HM, Mishra H, et al
    "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment.
    PLoS One. 2021;16:e0254211.
    PubMed     Abstract available


  132. MURALI S, Krishnamoorthy Y, Knudsen S, Roy G, et al
    Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India.
    PLoS One. 2021;16:e0256773.
    PubMed     Abstract available


  133. OHARA Y, Ozeki Y, Tateishi Y, Mashima T, et al
    Correction: Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.
    PLoS One. 2021;16:e0256946.
    PubMed     Abstract available


  134. OSEI-WUSU S, Otchere ID, Morgan P, Musah AB, et al
    Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.
    PLoS One. 2021;16:e0255433.
    PubMed     Abstract available


  135. CHETTY-MAKKAN CM, deSanto D, Lessells R, Charalambous S, et al
    Exploring the promise and reality of ward-based primary healthcare outreach teams conducting TB household contact tracing in three districts of South Africa.
    PLoS One. 2021;16:e0256033.
    PubMed     Abstract available


  136. LOXTON NW, Rohlwink UK, Tshavhungwe M, Dlamini L, et al
    A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.
    PLoS One. 2021;16:e0246997.
    PubMed     Abstract available


  137. ORESKOVIC A, Lutz BR
    Ultrasensitive hybridization capture: Reliable detection of <1 copy/mL short cell-free DNA from large-volume urine samples.
    PLoS One. 2021;16:e0247851.
    PubMed     Abstract available


  138. THAPA P, Jayasuriya R, Hall JJ, Beek K, et al
    Role of informal healthcare providers in tuberculosis care in low- and middle-income countries: A systematic scoping review.
    PLoS One. 2021;16:e0256795.
    PubMed     Abstract available


  139. KERKHOFF AD, Kagujje M, Nyangu S, Mateyo K, et al
    Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment.
    PLoS One. 2021;16:e0252095.
    PubMed     Abstract available


  140. BUTTLE TS, Hummerstone CY, Billahalli T, Ward RJB, et al
    The monocyte-to-lymphocyte ratio: Sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges.
    PLoS One. 2021;16:e0247745.
    PubMed     Abstract available


  141. JO Y, Kagujje M, Johnson K, Dowdy D, et al
    Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia.
    PLoS One. 2021;16:e0256531.
    PubMed     Abstract available


  142. NGOC NB, Vu Dinh H, Thuy NT, Quang DV, et al
    Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    PLoS One. 2021;16:e0255357.
    PubMed     Abstract available


  143. GOTHAM D, McKenna L, Deborggraeve S, Madoori S, et al
    Public investments in the development of GeneXpert molecular diagnostic technology.
    PLoS One. 2021;16:e0256883.
    PubMed     Abstract available


  144. DEVALRAJU KP, Neela VSK, Krovvidi SS, Vankayalapati R, et al
    Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.
    PLoS One. 2021;16:e0257185.
    PubMed     Abstract available


  145. GALLUCCI G, Santucci N, Diaz A, Bongiovanni B, et al
    Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement.
    PLoS One. 2021;16:e0257214.
    PubMed     Abstract available


  146. KIMANI E, Muhula S, Kiptai T, Orwa J, et al
    Factors influencing TB treatment interruption and treatment outcomes among patients in Kiambu County, 2016-2019.
    PLoS One. 2021;16:e0248820.
    PubMed     Abstract available


  147. PANRAKSA Y, Amin AG, Graham B, Henry CS, et al
    Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis.
    PLoS One. 2021;16:e0257615.
    PubMed     Abstract available


  148. GOPALAN N, Srinivasalu VA, Chinnayan P, Velayutham B, et al
    Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
    PLoS One. 2021;16:e0257647.
    PubMed     Abstract available


  149. WATURUOCHA UW, P J A, Singh KK, Malhotra V, et al
    A high-frequency single nucleotide polymorphism in the MtrB sensor kinase in clinical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties.
    PLoS One. 2021;16:e0256664.
    PubMed     Abstract available


  150. TAMENE W, Abebe M, Wassie L, Mollalign H, et al
    PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV.
    PLoS One. 2021;16:e0258122.
    PubMed     Abstract available


  151. ZVONAREVA O, Witte S, Kabanets N, Filinyuk O, et al
    Adolescents in a tuberculosis hospital: Qualitative study of how relationships with doctors, caregivers, and peers mediate their mental wellbeing.
    PLoS One. 2021;16:e0257379.
    PubMed     Abstract available


  152. NABITY SA, Gunde LJ, Surie D, Shiraishi RW, et al
    Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    PLoS One. 2021;16:e0248115.
    PubMed     Abstract available


  153. DIRIBA G, Tola HH, Alemu A, Yenew B, et al
    Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0258295.
    PubMed     Abstract available


  154. SANCHEZ-CORRALES L, Tovar-Aguirre OL, Galeano-Vanegas NF, Castano Jimenez PA, et al
    Phylogenomic analysis and Mycobacterium tuberculosis antibiotic resistance prediction by whole-genome sequencing from clinical isolates of Caldas, Colombia.
    PLoS One. 2021;16:e0258402.
    PubMed     Abstract available


  155. SUN L, Chen Y, Yi P, Yang L, et al
    Serological detection of Mycobacterium Tuberculosis complex infection in multiple hosts by One Universal ELISA.
    PLoS One. 2021;16:e0257920.
    PubMed     Abstract available


  156. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Correction: Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0258457.
    PubMed     Abstract available


  157. DOLLA CK, Dhanaraj B, Chandrasekaran P, Selvaraj S, et al
    Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India.
    PLoS One. 2021;16:e0247245.
    PubMed     Abstract available


  158. VON BOTH U, Gerlach P, Ritz N, Bogyi M, et al
    Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland.
    PLoS One. 2021;16:e0250387.
    PubMed     Abstract available


  159. APPIAH PK, Osei B, Amu H
    Factors associated with nutritional status, knowledge and attitudes among tuberculosis patients receiving treatment in Ghana: A cross-sectional study in the Tema Metropolis.
    PLoS One. 2021;16:e0258033.
    PubMed     Abstract available


  160. ALI MA, Balcha ES, Woldesemayat AA, Tirore LD, et al
    Combined assessment of tuberculosis case notification rate and infection control at health facilities of Dale districts, Sidama Zone, Southern Ethiopia.
    PLoS One. 2021;16:e0242446.
    PubMed     Abstract available


  161. ALLIE T, Jackson A, Ambler J, Johnston K, et al
    TBDBT: A TB DataBase Template for collection of harmonized TB clinical research data in REDCap, facilitating data standardisation for inter-study comparison and meta-analyses.
    PLoS One. 2021;16:e0249165.
    PubMed     Abstract available


  162. SPEKKER O, Hunt DR, Berthon W, Paja L, et al
    Tracking down the White Plague. Chapter three: Revision of endocranial abnormally pronounced digital impressions as paleopathological diagnostic criteria for tuberculous meningitis.
    PLoS One. 2021;16:e0249020.
    PubMed     Abstract available


  163. HOFFMANN J, Chedid C, Ocheretina O, Masetti C, et al
    Drug-resistant TB prevalence study in 5 health institutions in Haiti.
    PLoS One. 2021;16:e0248707.
    PubMed     Abstract available


  164. SINGH AR, Kumar A, Shewade HD, Dhingra B, et al
    Poor adherence to TB diagnosis guidelines among under-five children with severe acute malnutrition in central India: A missed window of opportunity?
    PLoS One. 2021;16:e0248192.
    PubMed     Abstract available


  165. DAS M, Mathur T, Ravi S, Meneguim AC, et al
    Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
    PLoS One. 2021;16:e0248408.
    PubMed     Abstract available


  166. GEIGER K, Stamper PD, Farley JE
    The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature.
    PLoS One. 2021;16:e0248174.
    PubMed     Abstract available


  167. SAHILE Z, Tezera R, Haile Mariam D, Collins J, et al
    Nutritional status and TB treatment outcomes in Addis Ababa, Ethiopia: An ambi-directional cohort study.
    PLoS One. 2021;16:e0247945.
    PubMed     Abstract available


    January 2020
  168. RUIZ-GROSSO P, Cachay R, de la Flor A, Schwalb A, et al
    Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227472.
    PubMed     Abstract available


  169. YAMAUCHI M, Kinjo T, Parrott G, Miyagi K, et al
    Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia.
    PLoS One. 2020;15:e0227636.
    PubMed     Abstract available


  170. MORASKI GC, Deboosere N, Marshall KL, Weaver HA, et al
    Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
    PLoS One. 2020;15:e0227224.
    PubMed     Abstract available


  171. ALENE KA, Viney K, Gray DJ, McBryde ES, et al
    Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
    PLoS One. 2020;15:e0227100.
    PubMed     Abstract available


  172. ERESO BM, Yimer SA, Gradmann C, Sagbakken M, et al
    Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study.
    PLoS One. 2020;15:e0226307.
    PubMed     Abstract available


  173. BRUGUERAS S, Molina VI, Casas X, Gonzalez YD, et al
    Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia.
    PLoS One. 2020;15:e0227291.
    PubMed     Abstract available


  174. MARAHATTA SB, Yadav RK, Giri D, Lama S, et al
    Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and western Nepal: A qualitative study among patients, community members and health care workers.
    PLoS One. 2020;15:e0227293.
    PubMed     Abstract available


  175. KUMAR SK, Arya S, Aggarwal A, Kapoor P, et al
    Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease.
    PLoS One. 2020;15:e0228359.
    PubMed     Abstract available


  176. YAKHELEF N, Audibert M, Ferlazzo G, Sitienei J, et al
    Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    PLoS One. 2020;15:e0227138.
    PubMed     Abstract available


  177. MARQUEZ C, Atukunda M, Balzer LB, Chamie G, et al
    The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda.
    PLoS One. 2020;15:e0228102.
    PubMed     Abstract available


  178. SAMPAIO VS, Rodrigues MGA, Silva LCFD, Castro DB, et al
    Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach.
    PLoS One. 2020;15:e0218359.
    PubMed     Abstract available


  179. ENGLE E, Gabrielian A, Long A, Hurt DE, et al
    Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis.
    PLoS One. 2020;15:e0224445.
    PubMed     Abstract available


  180. NYANGOMA M, Bajunirwe F, Atwine D
    Non-disclosure of tuberculosis diagnosis by patients to their household members in south western Uganda.
    PLoS One. 2020;15:e0216689.
    PubMed     Abstract available


  181. SAFAR HA, Mustafa AS, Amoudy HA, El-Hashim A, et al
    The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.
    PLoS One. 2020;15:e0228381.
    PubMed     Abstract available


  182. SARKAR A, Ghosh S, Shaw R, Patra MM, et al
    Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity.
    PLoS One. 2020;15:e0228657.
    PubMed     Abstract available


  183. SINGH H, Ramamohan V
    A model-based investigation into urban-rural disparities in tuberculosis treatment outcomes under the Revised National Tuberculosis Control Programme in India.
    PLoS One. 2020;15:e0228712.
    PubMed     Abstract available


  184. SHIBABAW A, Gelaw B, Gebreyes W, Robinson R, et al
    The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    PLoS One. 2020;15:e0229040.
    PubMed     Abstract available


  185. GOMEZ AC, Rodriguez-Fernandez P, Villar-Hernandez R, Gibert I, et al
    E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0228919.
    PubMed     Abstract available


  186. TOLA HH, Holakouie-Naieni K, Mansournia MA, Yaseri M, et al
    Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    PLoS One. 2020;15:e0229284.
    PubMed     Abstract available


  187. SAMPAIO VS, Rodrigues MGA, Silva LCFD, Castro DB, et al
    Correction: Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach.
    PLoS One. 2020;15:e0229749.
    PubMed     Abstract available


  188. ARPAGAUS A, Franzeck FC, Sikalengo G, Ndege R, et al
    Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort.
    PLoS One. 2020;15:e0229875.
    PubMed     Abstract available


  189. TUCCI P, Portela M, Chetto CR, Gonzalez-Sapienza G, et al
    Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate.
    PLoS One. 2020;15:e0221837.
    PubMed     Abstract available


  190. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    PLoS One. 2020;15:e0229691.
    PubMed     Abstract available


  191. OU X, Li Q, Su D, Xia H, et al
    A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples.
    PLoS One. 2020;15:e0228312.
    PubMed     Abstract available


  192. NACARAPA E, Muchiri E, Moon TD, Charalambous S, et al
    Effect of Xpert MTB/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural southern Mozambique. A retrospective cohort study.
    PLoS One. 2020;15:e0229995.
    PubMed     Abstract available


  193. DER JB, Grint D, Narh CT, Bonsu F, et al
    Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.
    PLoS One. 2020;15:e0230604.
    PubMed     Abstract available


  194. SHIFERAW MB, Sisay Misganaw A
    Evaluation of continuous quality improvement of tuberculosis and HIV diagnostic services in Amhara Public Health Institute, Ethiopia.
    PLoS One. 2020;15:e0230532.
    PubMed     Abstract available


  195. MACPHERSON P, Lebina L, Motsomi K, Bosch Z, et al
    Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.
    PLoS One. 2020;15:e0230376.
    PubMed     Abstract available


  196. SRIVASTAVA S, Chapagain M, Gumbo T
    Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis.
    PLoS One. 2020;15:e0230927.
    PubMed     Abstract available


  197. SUN HY, Wang JY, Chen YC, Hsueh PR, et al
    Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan.
    PLoS One. 2020;15:e0230067.
    PubMed     Abstract available


  198. ARINAMINPATHY N, Gomez GB, Sachdeva KS, Rao R, et al
    The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
    PLoS One. 2020;15:e0230808.
    PubMed     Abstract available


  199. LOBIE TA, Woldeamanuel Y, Asrat D, Beyene D, et al
    Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    PLoS One. 2020;15:e0231320.
    PubMed     Abstract available


  200. MOORE BK, Erasmus L, Ershova J, Smith SE, et al
    Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008-2010.
    PLoS One. 2020;15:e0230504.
    PubMed     Abstract available


  201. HUSSAIN T, Tripathy SS, Das S, Satapathy P, et al
    Prevalence, risk factors and health seeking behaviour of pulmonary tuberculosis in four tribal dominated districts of Odisha: Comparison with studies in other regions of India.
    PLoS One. 2020;15:e0227083.
    PubMed     Abstract available


  202. BEUTLER M, Plesnik S, Mihalic M, Olbrich L, et al
    A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.
    PLoS One. 2020;15:e0227215.
    PubMed     Abstract available


  203. HONG JH, Yoon SH, Goo JM, Yim JJ, et al
    Clustered micronodules as predominant manifestation on CT: A sign of active but indolently evolving pulmonary tuberculosis.
    PLoS One. 2020;15:e0231537.
    PubMed     Abstract available


  204. VARELA-CASTRO L, Alvarez V, Sevilla IA, Barral M, et al
    Risk factors associated to a high Mycobacterium tuberculosis complex seroprevalence in wild boar (Sus scrofa) from a low bovine tuberculosis prevalence area.
    PLoS One. 2020;15:e0231559.
    PubMed     Abstract available


  205. HU J, Jin K, He ZG, Zhang H, et al
    Citrate lyase CitE in Mycobacterium tuberculosis contributes to mycobacterial survival under hypoxic conditions.
    PLoS One. 2020;15:e0230786.
    PubMed     Abstract available


  206. KAEWSEEKHAO B, Roytrakul S, Yingchutrakul Y, Salao K, et al
    Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis.
    PLoS One. 2020;15:e0231834.
    PubMed     Abstract available


  207. RAJAVEL S, Raghav P, Gupta MK, Muralidhar V, et al
    Silico-tuberculosis, silicosis and other respiratory morbidities among sandstone mine workers in Rajasthan- a cross-sectional study.
    PLoS One. 2020;15:e0230574.
    PubMed     Abstract available


  208. JO Y, Mirzoeva F, Chry M, Qin ZZ, et al
    Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan.
    PLoS One. 2020;15:e0228216.
    PubMed     Abstract available


  209. NIETO RAMIREZ LM, Ferro BE, Diaz G, Anthony RM, et al
    Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia.
    PLoS One. 2020;15:e0224908.
    PubMed     Abstract available


  210. NGUYEN HV, Tiemersma EW, Nguyen HB, Cobelens FGJ, et al
    The second national tuberculosis prevalence survey in Vietnam.
    PLoS One. 2020;15:e0232142.
    PubMed     Abstract available


  211. MIGAMBI P, Gasana M, Uwizeye CB, Kamanzi E, et al
    Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.
    PLoS One. 2020;15:e0231372.
    PubMed     Abstract available


  212. TOK PSK, Liew SM, Wong LP, Razali A, et al
    Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study.
    PLoS One. 2020;15:e0231986.
    PubMed     Abstract available


  213. CHIRENDA J, Gwitira I, Warren RM, Sampson SL, et al
    Spatial distribution of Mycobacterium Tuberculosis in metropolitan Harare, Zimbabwe.
    PLoS One. 2020;15:e0231637.
    PubMed     Abstract available


  214. DESAI AN, Seshasayee SM, Majumder MS, Lassmann B, et al
    Tuberculosis and foreign-born populations in the United States: A mixed methods pilot study of media reporting and political identification.
    PLoS One. 2020;15:e0230967.
    PubMed     Abstract available


  215. HUIBERS MHW, Bates I, McKew S, Allain TJ, et al
    Severe anaemia complicating HIV in Malawi; Multiple co-existing aetiologies are associated with high mortality.
    PLoS One. 2020;15:e0218695.
    PubMed     Abstract available


  216. MATAMBO R, Takarinda KC, Thekkur P, Sandy C, et al
    Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.
    PLoS One. 2020;15:e0230848.
    PubMed     Abstract available


  217. TESEMA T, Seyoum D, Ejeta E, Tsegaye R, et al
    Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia.
    PLoS One. 2020;15:e0232468.
    PubMed     Abstract available


  218. WANG N, Shewade HD, Thekkur P, Huang F, et al
    Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China.
    PLoS One. 2020;15:e0232337.
    PubMed     Abstract available


  219. TAHSEEN S, Khanzada FM, Baloch AQ, Abbas Q, et al
    Extrapulmonary tuberculosis in Pakistan- A nation-wide multicenter retrospective study.
    PLoS One. 2020;15:e0232134.
    PubMed     Abstract available


  220. MWAURA M, Kao K, Wambugu J, Trollip A, et al
    Situating trade-offs: Stakeholder perspectives on overtreatment versus missed diagnosis in transition to Xpert MTB/RIF Ultra in Kenya and Swaziland.
    PLoS One. 2020;15:e0228669.
    PubMed     Abstract available


  221. ROWNEKI M, Aronson N, Du P, Sachs P, et al
    Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
    PLoS One. 2020;15:e0232343.
    PubMed     Abstract available


  222. ALEMU A, Yesuf A, Gebrehanna E, Zerihun B, et al
    Incidence and predictors of extrapulmonary tuberculosis among people living with Human Immunodeficiency Virus in Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2020;15:e0232426.
    PubMed     Abstract available


  223. BISOGNIN F, Lombardi G, Finelli C, Re MC, et al
    Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB(R) Kit for the diagnosis of tuberculosis.
    PLoS One. 2020;15:e0232632.
    PubMed     Abstract available


  224. NALUYANGE R, Mboowa G, Komakech K, Semugenze D, et al
    High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2020;15:e0232543.
    PubMed     Abstract available


  225. LISBOA M, Fronteira I, Mason PH, Martins MDRO, et al
    National TB program shortages as potential factor for poor-quality TB care cascade: Healthcare workers' perspective from Beira, Mozambique.
    PLoS One. 2020;15:e0228927.
    PubMed     Abstract available


  226. CHEKESA B, Gumi B, Chanyalew M, Zewude A, et al
    Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.
    PLoS One. 2020;15:e0233314.
    PubMed     Abstract available


  227. MARTINEZ-GUIJOSA J, Romero B, Infantes-Lorenzo JA, Diez E, et al
    Environmental DNA: A promising factor for tuberculosis risk assessment in multi-host settings.
    PLoS One. 2020;15:e0233837.
    PubMed     Abstract available


  228. DEMEMEW ZG, Jerene D, Datiko DG, Hiruy N, et al
    The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: A cross-sectional implementation study.
    PLoS One. 2020;15:e0233730.
    PubMed     Abstract available


  229. YU EA, Finkelstein JL, Brannon PM, Bonam W, et al
    Nutritional assessment among adult patients with suspected or confirmed active tuberculosis disease in rural India.
    PLoS One. 2020;15:e0233306.
    PubMed     Abstract available


  230. TESFAYE L, Lemu YK, Tareke KG, Chaka M, et al
    Exploration of barriers and facilitators to household contact tracing of index tuberculosis cases in Anlemo district, Hadiya zone, Southern Ethiopia: Qualitative study.
    PLoS One. 2020;15:e0233358.
    PubMed     Abstract available


  231. WOLDAY D, Kebede Y, Legesse D, Siraj DS, et al
    Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    PLoS One. 2020;15:e0233049.
    PubMed     Abstract available


  232. HOLDEN IK, Lillebaek T, Andersen PH, Wejse C, et al
    Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study.
    PLoS One. 2020;15:e0231821.
    PubMed     Abstract available


  233. JAGANATH D, Rajan J, Yoon C, Ravindran R, et al
    Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV.
    PLoS One. 2020;15:e0234130.
    PubMed     Abstract available


  234. GEHLEN M, Costa ERD, Rossetti MLR, Silva DR, et al
    Macrophage migration inhibitory factor -173 G>C single nucleotide polymorphism and its association with active pulmonary tuberculosis.
    PLoS One. 2020;15:e0234565.
    PubMed     Abstract available


  235. KAKINDA M, Matovu JKB
    A yield and cost comparison of tuberculosis contact investigation and intensified case finding in Uganda.
    PLoS One. 2020;15:e0234418.
    PubMed     Abstract available


  236. LEE GO, Comina G, Hernandez-Cordova G, Naik N, et al
    Cough dynamics in adults receiving tuberculosis treatment.
    PLoS One. 2020;15:e0231167.
    PubMed     Abstract available


  237. KIM OH, Jo KW, Park S, Jo YH, et al
    Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    PLoS One. 2020;15:e0234700.
    PubMed     Abstract available


  238. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2020;15:e0234651.
    PubMed     Abstract available


  239. RUFAI SB, Umay K, Singh PK, Singh S, et al
    Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective.
    PLoS One. 2020;15:e0229419.
    PubMed     Abstract available


  240. SAFE IP, Lacerda MVG, Printes VS, Praia Marins AF, et al
    Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study).
    PLoS One. 2020;15:e0235381.
    PubMed     Abstract available


  241. KIM SB, Lee WY, Lee JH, Lee SJ, et al
    A variety of bacterial aetiologies in the lower respiratory tract at patients with endobronchial tuberculosis.
    PLoS One. 2020;15:e0234558.
    PubMed     Abstract available


  242. OSEI E, Oppong S, Der J
    Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study.
    PLoS One. 2020;15:e0234878.
    PubMed     Abstract available


  243. GENET C, Andualem T, Melese A, Mulu W, et al
    Quality of care for tuberculosis patients in public health facilities of Debre Tabor town, Northwest Ethiopia.
    PLoS One. 2020;15:e0234988.
    PubMed     Abstract available


  244. KYAW KWY, Kyaw NTT, Kyi MS, Aye S, et al
    HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017.
    PLoS One. 2020;15:e0234429.
    PubMed     Abstract available


  245. SPEKKER O, Hunt DR, Paja L, Molnar E, et al
    Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection.
    PLoS One. 2020;15:e0230418.
    PubMed     Abstract available


  246. OTIENDE VA, Achia TN, Mwambi HG
    Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in Kenya.
    PLoS One. 2020;15:e0234456.
    PubMed     Abstract available


  247. BUNYASI EW, Mulenga H, Luabeya AKK, Shenje J, et al
    Regional changes in tuberculosis disease burden among adolescents in South Africa (2005-2015).
    PLoS One. 2020;15:e0235206.
    PubMed     Abstract available


  248. AREFAINE ZG, Abebe S, Bekele E, Adem A, et al
    Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
    PLoS One. 2020;15:e0229757.
    PubMed     Abstract available


  249. BASHAM CA, Smith SJ, Romanowski K, Johnston JC, et al
    Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235821.
    PubMed     Abstract available


  250. BAHRAINWALA L, Knoblauch AM, Andriamiadanarivo A, Diab MM, et al
    Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis.
    PLoS One. 2020;15:e0235572.
    PubMed     Abstract available


  251. KIM S, de Los Reyes V AA, Jung E
    Country-specific intervention strategies for top three TB burden countries using mathematical model.
    PLoS One. 2020;15:e0230964.
    PubMed     Abstract available


  252. NGUYEN HV, Tiemersma EW, Nguyen HB, Cobelens FGJ, et al
    Correction: The second national tuberculosis prevalence survey in Vietnam.
    PLoS One. 2020;15:e0236532.
    PubMed     Abstract available


  253. LEAL DFDVB, Santana da Silva MN, Fernandes DCRO, Rodrigues JCG, et al
    Amerindian genetic ancestry as a risk factor for tuberculosis in an amazonian population.
    PLoS One. 2020;15:e0236033.
    PubMed     Abstract available


  254. TANEJA V, Kalra P, Goel M, Khilnani GC, et al
    Impact and prognosis of the expression of IFN-alpha among tuberculosis patients.
    PLoS One. 2020;15:e0235488.
    PubMed     Abstract available


  255. SEMA BALTAZAR C, DeLima YV, Ricardo H, Botao C, et al
    HIV prevalence and TB in migrant miners communities of origin in Gaza Province, Mozambique: The need for increasing awareness and knowledge.
    PLoS One. 2020;15:e0231303.
    PubMed     Abstract available


  256. KUDDUS MA, Meehan MT, White LJ, McBryde ES, et al
    Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh.
    PLoS One. 2020;15:e0236112.
    PubMed     Abstract available


  257. TOONKOMDANG S, Phinyo P, Phetsuksiri B, Patumanond J, et al
    Pragmatic accuracy of an in-house loop-mediated isothermal amplification (LAMP) for diagnosis of pulmonary tuberculosis in a Thai community hospital.
    PLoS One. 2020;15:e0236496.
    PubMed     Abstract available


  258. KWON BS, Kim Y, Lee SH, Lim SY, et al
    The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis.
    PLoS One. 2020;15:e0236109.
    PubMed     Abstract available


  259. ESTEVEZ O, Anibarro L, Garet E, Pallares A, et al
    Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.
    PLoS One. 2020;15:e0235859.
    PubMed     Abstract available


  260. CASAS I, Esteve M, Guerola R, Latorre I, et al
    Serial testing of health care workers for tuberculosis infection: A prospective cohort study.
    PLoS One. 2020;15:e0235986.
    PubMed     Abstract available


  261. SUPO-ESCALANTE RR, Medico A, Gushiken E, Olivos-Ramirez GE, et al
    Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
    PLoS One. 2020;15:e0235643.
    PubMed     Abstract available


  262. SOBOKA M, Tolessa O, Tesfaye M, Adorjan K, et al
    Magnitude and predictors of khat use among patients with tuberculosis in Southwest Ethiopia: A longitudinal study.
    PLoS One. 2020;15:e0236154.
    PubMed     Abstract available


  263. PARADKAR M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, et al
    Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0236743.
    PubMed     Abstract available


  264. TENZIN C, Chansatitporn N, Dendup T, Dorji T, et al
    Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study.
    PLoS One. 2020;15:e0236250.
    PubMed     Abstract available


  265. ALEMAYEHU S, Yigezu A, Hailemariam D, Hailu A, et al
    Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.
    PLoS One. 2020;15:e0235820.
    PubMed     Abstract available


  266. ZHU QQ, Wu Q, Wang AM, Bao FJ, et al
    Epidemiological characteristics of pulmonary tuberculosis in Anhui Province, Eastern China from 2013 to 2018.
    PLoS One. 2020;15:e0237311.
    PubMed     Abstract available


  267. NIKI M, Yoshiyama T, Nagai H, Miyamoto Y, et al
    Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development.
    PLoS One. 2020;15:e0237062.
    PubMed     Abstract available


  268. SHINU P, Singh VA, Nair A, Venugopala KN, et al
    Papain-cetylpyridinium chloride and pepsin-cetylpyridinium chloride; two novel, highly sensitive, concentration, digestion and decontamination techniques for culturing mycobacteria from clinically suspected pulmonary tuberculosis cases.
    PLoS One. 2020;15:e0236700.
    PubMed     Abstract available


  269. KASHONGWE IM, Mawete F, Mbulula L, Nsuela DJ, et al
    Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study.
    PLoS One. 2020;15:e0236264.
    PubMed     Abstract available


  270. TILAHUN M, Shimelis E, Wogayehu T, Assefa G, et al
    Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0236054.
    PubMed     Abstract available


  271. GRANDE SW, Adams LV, Maseko TSB, Talbot EA, et al
    The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
    PLoS One. 2020;15:e0232841.
    PubMed     Abstract available


  272. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available


  273. HASSANE-HAROUNA S, Cherif GF, Ortuno-Gutierrez N, Cisse D, et al
    Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study.
    PLoS One. 2020;15:e0237355.
    PubMed     Abstract available


  274. PANDEY P, Bhatnagar AK, Mohan A, Sachdeva KS, et al
    Mycobacterium tuberculosis polyclonal infections through treatment and recurrence.
    PLoS One. 2020;15:e0237345.
    PubMed     Abstract available


  275. EDESSA D, Sisay M, Dessie Y
    Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237534.
    PubMed     Abstract available


  276. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0236362.
    PubMed     Abstract available


  277. DABHI PA, Thangakunam B, Gupta R, James P, et al
    Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital.
    PLoS One. 2020;15:e0233385.
    PubMed     Abstract available


  278. VAN DEUN A, Decroo T, Kya Jai Maug A, Hossain MA, et al
    The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
    PLoS One. 2020;15:e0233500.
    PubMed     Abstract available


  279. O'CONNELL J, de Barra E, McConkey S
    Hospital inpatient care utilization among patients with tuberculosis, Republic of Ireland, 2015-2018.
    PLoS One. 2020;15:e0238142.
    PubMed     Abstract available


  280. SHARMA P, Anthwal D, Kumari P, Gupta RK, et al
    Utility of circulating cell-free Mycobacterium tuberculosis DNA for the improved diagnosis of abdominal tuberculosis.
    PLoS One. 2020;15:e0238119.
    PubMed     Abstract available


  281. MESIC A, Khan WH, Lenglet A, Lynen L, et al
    Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
    PLoS One. 2020;15:e0237787.
    PubMed     Abstract available


  282. TEDLA K, Medhin G, Berhe G, Mulugeta A, et al
    Factors associated with treatment initiation delay among new adult pulmonary tuberculosis patients in Tigray, Northern Ethiopia.
    PLoS One. 2020;15:e0235411.
    PubMed     Abstract available


  283. KANG W, Yu J, Du J, Yang S, et al
    The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study.
    PLoS One. 2020;15:e0237753.
    PubMed     Abstract available


  284. MULENGA H, Zauchenberger CZ, Bunyasi EW, Mbandi SK, et al
    Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237574.
    PubMed     Abstract available


  285. AGIZEW T, Boyd R, Mathebula U, Mathoma A, et al
    Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    PLoS One. 2020;15:e0234646.
    PubMed     Abstract available


  286. ALBERT H, Purcell R, Wang YY, Kao K, et al
    Designing an optimized diagnostic network to improve access to TB diagnosis and treatment in Lesotho.
    PLoS One. 2020;15:e0233620.
    PubMed     Abstract available


  287. OSPINA JE, Orcau A, Millet JP, Ros M, et al
    Correction: Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    PLoS One. 2020;15:e0238963.
    PubMed     Abstract available


  288. PATTERSON B, Dinkele R, Gessner S, Morrow C, et al
    Sensitivity optimisation of tuberculosis bioaerosol sampling.
    PLoS One. 2020;15:e0238193.
    PubMed     Abstract available


  289. TIAMIYU AB, Iliyasu G, Dayyab FM, Habib ZG, et al
    A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient's population in North Central Nigeria.
    PLoS One. 2020;15:e0238007.
    PubMed     Abstract available


  290. DECROO T, Maug AKJ, Hossain MA, Uwizeye C, et al
    Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.
    PLoS One. 2020;15:e0238016.
    PubMed     Abstract available


  291. HUANG Y, Huang J, Su X, Chen L, et al
    Analysis of the economic burden of diagnosis and treatment on patients with tuberculosis in Bao'an district of Shenzhen City, China.
    PLoS One. 2020;15:e0237865.
    PubMed     Abstract available


  292. FERNANDO R, McDowell AC, Bhavaraju R, Fraimow H, et al
    A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017.
    PLoS One. 2020;15:e0236933.
    PubMed     Abstract available


  293. PARK JH, Kim N, Park H, Kim TS, et al
    The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers.
    PLoS One. 2020;15:e0235254.
    PubMed     Abstract available


  294. ODAFE S, Onotu D, Fagbamigbe JO, Ene U, et al
    Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities-Nigeria, 2016-2017.
    PLoS One. 2020;15:e0234717.
    PubMed     Abstract available


  295. KATHAMUTHU GR, Moideen K, Kumar NP, Sridhar R, et al
    Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment.
    PLoS One. 2020;15:e0233426.
    PubMed     Abstract available


  296. BURUSIE A, Enquesilassie F, Addissie A, Dessalegn B, et al
    Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0239333.
    PubMed     Abstract available


  297. CATALA M, Prats C, Lopez D, Cardona PJ, et al
    A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection.
    PLoS One. 2020;15:e0239289.
    PubMed     Abstract available


  298. BITEW ZW, Alebel A, Worku T, Alemu A, et al
    Recovery rate and its predictors among children with severe acute malnutrition in Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2020;15:e0235259.
    PubMed     Abstract available


  299. MUYINDIKE WR, Fatch R, Cheng DM, Emenyonu NI, et al
    Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda.
    PLoS One. 2020;15:e0235261.
    PubMed     Abstract available


  300. KONDRATIEVA T, Shleeva M, Kapina M, Rubakova E, et al
    Prolonged infection triggered by dormant Mycobacterium tuberculosis: Immune and inflammatory responses in lungs of genetically susceptible and resistant mice.
    PLoS One. 2020;15:e0239668.
    PubMed     Abstract available


  301. WALT MV, Masuku S, Botha S, Nkwenika T, et al
    Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.
    PLoS One. 2020;15:e0239018.
    PubMed     Abstract available


  302. TAHSEEN S, Khanzada FM, Rizvi AH, Qadir M, et al
    Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
    PLoS One. 2020;15:e0239328.
    PubMed     Abstract available


  303. TADESSE AW, Alagaw A, Kassa M, Bekele M, et al
    Tuberculosis infection control practices and associated factors among healthcare workers in hospitals of Gamo Gofa Zone, Southern Ethiopia, institution-based cross-sectional study.
    PLoS One. 2020;15:e0239159.
    PubMed     Abstract available


  304. JOSE B, Manhica I, Jones J, Mutaquiha C, et al
    Using community health workers for facility and community based TB case finding: An evaluation in central Mozambique.
    PLoS One. 2020;15:e0236262.
    PubMed     Abstract available


  305. SALIFU RS, Hlongwana KW
    Barriers and facilitators to bidirectional screening of TB-DM in Ghana: Healthcare workers' perspectives.
    PLoS One. 2020;15:e0235914.
    PubMed     Abstract available


  306. MAIR L, Corbett EL, Feasey HRA, Kamchedzera W, et al
    Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi.
    PLoS One. 2020;15:e0236407.
    PubMed     Abstract available


  307. KALRA A, Parija D, Raizada N, Sachdeva KS, et al
    Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    PLoS One. 2020;15:e0236057.
    PubMed     Abstract available


  308. NACHER M, Adenis A, Guarmit B, Lucarelli A, et al
    What is AIDS in the Amazon and the Guianas in the 90-90-90 era?
    PLoS One. 2020;15:e0236368.
    PubMed     Abstract available


  309. ANKU PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A, et al
    Challenges of scaling-up of TB-HIV integrated service delivery in Ghana.
    PLoS One. 2020;15:e0235843.
    PubMed     Abstract available


  310. SAYEDI SM, Seddiq MK, Rashidi MK, Qader G, et al
    Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan.
    PLoS One. 2020;15:e0240031.
    PubMed     Abstract available


  311. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available


  312. LINCE-DEROCHE N, Leuner R, Kgowedi S, Moolla A, et al
    Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa.
    PLoS One. 2020;15:e0230849.
    PubMed     Abstract available


  313. KRISHNAKUMARIAMMA K, Ellappan K, Muthuraj M, Tamilarasu K, et al
    Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    PLoS One. 2020;15:e0240257.
    PubMed     Abstract available


  314. SHIN HS, Choi DS, Na JB, Choi HY, et al
    Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.
    PLoS One. 2020;15:e0239431.
    PubMed     Abstract available


  315. SALA C, Benjak A, Goletti D, Banu S, et al
    Multicenter analysis of sputum microbiota in tuberculosis patients.
    PLoS One. 2020;15:e0240250.
    PubMed     Abstract available


  316. TING NCH, El-Turk N, Chou MSH, Dobler CC, et al
    Patient-perceived treatment burden of tuberculosis treatment.
    PLoS One. 2020;15:e0241124.
    PubMed     Abstract available


  317. TAN C, Kallon II, Colvin CJ, Grant AD, et al
    Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
    PLoS One. 2020;15:e0241039.
    PubMed     Abstract available


  318. NGUIPDOP-DJOMO P, Rodrigues LC, Abubakar I, Mangtani P, et al
    Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
    PLoS One. 2020;15:e0240879.
    PubMed     Abstract available


  319. BROOKS MB, Mitnick CD, Manjourides J
    Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
    PLoS One. 2020;15:e0240297.
    PubMed     Abstract available


  320. MBUTHIA GW, Nyamogoba HDN, Chiang SS, McGarvey ST, et al
    Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study.
    PLoS One. 2020;15:e0240457.
    PubMed     Abstract available


  321. VELAYUTHAM B, Jayabal L, Watson B, Jagadeesan S, et al
    Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    PLoS One. 2020;15:e0240594.
    PubMed     Abstract available


  322. MERID MW, Muluneh AG, Yenit MK, Kassa GM, et al
    Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.
    PLoS One. 2020;15:e0240564.
    PubMed     Abstract available


  323. KAGUJJE M, Chilukutu L, Somwe P, Mutale J, et al
    Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.
    PLoS One. 2020;15:e0237931.
    PubMed     Abstract available


  324. ALAO MA, Maroushek SR, Chan YH, Asinobi AO, et al
    Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center.
    PLoS One. 2020;15:e0239225.
    PubMed     Abstract available


  325. RAMOS-SONO D, Laureano R, Rueda D, Gilman RH, et al
    An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples.
    PLoS One. 2020;15:e0241067.
    PubMed     Abstract available


  326. BIERMANN O, Tran PB, Viney K, Caws M, et al
    Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review.
    PLoS One. 2020;15:e0240696.
    PubMed     Abstract available


  327. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    PubMed     Abstract available


  328. SPEKKER O, Schultz M, Paja L, Varadi OA, et al
    Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis.
    PLoS One. 2020;15:e0238444.
    PubMed     Abstract available


  329. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0241600.
    PubMed     Abstract available


  330. WAHEDI K, Biddle L, Bozorgmehr K
    Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).
    PLoS One. 2020;15:e0241852.
    PubMed     Abstract available


  331. WASIHUN AG, Dejene TA, Hailu GG
    Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0240361.
    PubMed     Abstract available


  332. GOTHAM D, McKenna L, Frick M, Lessem E, et al
    Public investments in the clinical development of bedaquiline.
    PLoS One. 2020;15:e0239118.
    PubMed     Abstract available


  333. BALOGUN OS, Gao XZ, Jolayemi ET, Olaleye SA, et al
    Generalized cure rate model for infectious diseases with possible co-infections.
    PLoS One. 2020;15:e0239003.
    PubMed     Abstract available


  334. CHITTAMANY P, Yamanaka T, Suthepmany S, Sorsavanh T, et al
    First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    PLoS One. 2020;15:e0241862.
    PubMed     Abstract available


  335. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    Correction: A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2020;15:e0242455.
    PubMed     Abstract available


  336. ISLAM SKS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2020;15:e0241717.
    PubMed     Abstract available


  337. GEZAHEGN LK, Argaw E, Assefa B, Geberesilassie A, et al
    Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0241346.
    PubMed     Abstract available


  338. BONNEWELL JP, Farrow L, Dicks KV, Cox GM, et al
    Geographic analysis of latent tuberculosis screening: A health system approach.
    PLoS One. 2020;15:e0242055.
    PubMed     Abstract available


  339. WANG N, Shewade HD, Thekkur P, Zhang H, et al
    Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China.
    PLoS One. 2020;15:e0242112.
    PubMed     Abstract available


  340. WIARDA JE, Boggiatto PM, Bayles DO, Waters WR, et al
    Severity of bovine tuberculosis is associated with innate immune-biased transcriptional signatures of whole blood in early weeks after experimental Mycobacterium bovis infection.
    PLoS One. 2020;15:e0239938.
    PubMed     Abstract available


  341. MAYITO J, Meya DB, Rhein J, Sekaggya-Wiltshire C, et al
    Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen.
    PLoS One. 2020;15:e0241786.
    PubMed     Abstract available


  342. BADE AB, Mega TA
    Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    PLoS One. 2020;15:e0241684.
    PubMed     Abstract available


  343. SANOGO B, Ouermi AS, Barro M, Millogo A, et al
    Performance of a lymphocyte t interferon gamma test (Quantiferon-TB gold in tube) in the diagnosis of active tuberculosis in HIV-infected children.
    PLoS One. 2020;15:e0241789.
    PubMed     Abstract available


  344. DORJI T, Tshering T, Wangdi K
    Assessment of knowledge, attitude and practice on tuberculosis among teacher trainees of Samtse College of Education, Bhutan.
    PLoS One. 2020;15:e0241923.
    PubMed     Abstract available


  345. KUNDU J, Bakshi S, Joshi H, Bhadada SK, et al
    Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis - A pilot study.
    PLoS One. 2020;15:e0233326.
    PubMed     Abstract available


  346. DARMA S, Ambara A, Aman AT, Annisa L, et al
    High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    PLoS One. 2020;15:e0242542.
    PubMed     Abstract available


  347. KETEMA L, Dememew ZG, Assefa D, Gudina T, et al
    Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study.
    PLoS One. 2020;15:e0241977.
    PubMed     Abstract available


  348. FLINT L, Korkegian A, Parish T
    InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0239354.
    PubMed     Abstract available


  349. WELDEMHRET L, Hailu A, Gebremedhn G, Bekuretsion H, et al
    Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study.
    PLoS One. 2020;15:e0239342.
    PubMed     Abstract available


  350. HORTER S, Achar J, Gray N, Parpieva N, et al
    Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    PLoS One. 2020;15:e0242359.
    PubMed     Abstract available


  351. BANU S, Haque F, Ahmed S, Sultana S, et al
    Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.
    PLoS One. 2020;15:e0241437.
    PubMed     Abstract available


  352. AJUDUA FI, Mash RJ
    Implementing active surveillance for TB-The views of managers in a resource limited setting, South Africa.
    PLoS One. 2020;15:e0239430.
    PubMed     Abstract available


  353. HAUK C, Schafermann S, Martus P, Muzafarova N, et al
    Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis.
    PLoS One. 2020;15:e0243428.
    PubMed     Abstract available


  354. STOCKBRIDGE EL, Loethen AD, Annan E, Miller TL, et al
    Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    PLoS One. 2020;15:e0243102.
    PubMed     Abstract available


  355. LI Y, Pang Y, Zhang T, Xian X, et al
    Genotypes of Mycobacterium tuberculosis isolates circulating in Shaanxi Province, China.
    PLoS One. 2020;15:e0242971.
    PubMed     Abstract available


  356. WANG D, Tong X, Wang L, Zhang S, et al
    The association between osteopontin and tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0242702.
    PubMed     Abstract available


  357. YU G, Zhao W, Shen Y, Zhu P, et al
    Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243161.
    PubMed     Abstract available


  358. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2020;15:e0241065.
    PubMed     Abstract available


  359. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    PubMed     Abstract available


  360. KITONSA PJ, Nalutaaya A, Mukiibi J, Nakasolya O, et al
    Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis.
    PLoS One. 2020;15:e0243542.
    PubMed     Abstract available


  361. MOHAMMEDHUSSEIN M, Hajure M, Shifa JE, Hassen TA, et al
    Perceived stigma among patient with pulmonary tuberculosis at public health facilities in southwest Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0243433.
    PubMed     Abstract available


  362. DIRIBA G, Kebede A, Tola HH, Yenew B, et al
    Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0243493.
    PubMed     Abstract available


  363. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available


  364. KOLTE IV, Pereira L, Benites A, de Sousa IMC, et al
    The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil.
    PLoS One. 2020;15:e0243988.
    PubMed     Abstract available


  365. AREGA B, Mersha A, Minda A, Getachew Y, et al
    Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia.
    PLoS One. 2020;15:e0243945.
    PubMed     Abstract available


  366. KOSGEI RJ, Callens S, Gichangi P, Temmerman M, et al
    Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya.
    PLoS One. 2020;15:e0243977.
    PubMed     Abstract available


  367. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis: A protocol.
    PLoS One. 2020;15:e0243765.
    PubMed     Abstract available


  368. GADICHERLA S, Krishnappa L, Madhuri B, Mitra SG, et al
    Envisioning a learning surveillance system for tuberculosis.
    PLoS One. 2020;15:e0243610.
    PubMed     Abstract available


  369. ALI N, Bello GL, Rossetti MLR, Krieger MA, et al
    Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study.
    PLoS One. 2020;15:e0242408.
    PubMed     Abstract available


  370. MEJIA-PAILLES G, Berrington A, McGrath N, Hosegood V, et al
    Trends in the prevalence and incidence of orphanhood in children and adolescents <20 years in rural KwaZulu-Natal South Africa, 2000-2014.
    PLoS One. 2020;15:e0238563.
    PubMed     Abstract available


  371. HOPKINS KL, Hlongwane KE, Otwombe K, Dietrich J, et al
    Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa.
    PLoS One. 2020;15:e0241014.
    PubMed     Abstract available


  372. LOVEDAY M, Hlangu S, Furin J
    "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    PLoS One. 2020;15:e0242604.
    PubMed     Abstract available


  373. ZAWEDDE-MUYANJA S, Musaazi J, Manabe YC, Katamba A, et al
    Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
    PLoS One. 2020;15:e0241611.
    PubMed     Abstract available



  374. Correction: Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0244914.
    PubMed     Abstract available


  375. NONGHANPHITHAK D, Kaewprasert O, Chaiyachat P, Reechaipichitkul W, et al
    Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    PLoS One. 2020;15:e0244829.
    PubMed     Abstract available


  376. PARK JW, Curtis JR, Lee H, Lee JK, et al
    Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    PLoS One. 2020;15:e0244239.
    PubMed     Abstract available


  377. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    PubMed     Abstract available


  378. DIAN S, Hermawan R, van Laarhoven A, Immaculata S, et al
    Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis.
    PLoS One. 2020;15:e0241974.
    PubMed     Abstract available


  379. ANANTHAKRISHNAN R, Thiagesan R, Auguesteen S, Karunakaran N, et al
    The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    PLoS One. 2020;15:e0241203.
    PubMed     Abstract available


  380. BORNMANN L, Haunschild R, Patel VM
    Are papers addressing certain diseases perceived where these diseases are prevalent? The proposal to use Twitter data as social-spatial sensors.
    PLoS One. 2020;15:e0242550.
    PubMed     Abstract available


  381. DE MEDEIROS VLS, Santos FCF, Montenegro LML, Silva MDC, et al
    TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients.
    PLoS One. 2020;15:e0242098.
    PubMed     Abstract available


  382. KARANJA M, Kingwara L, Owiti P, Kirui E, et al
    Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    PLoS One. 2020;15:e0234588.
    PubMed     Abstract available


  383. SOMNUKE P, Ramlee R, Ratanapaiboon W, Thommaaksorn P, et al
    Factors influencing preoperative chest radiography request for elective endoscopic procedures among medical personnel.
    PLoS One. 2020;15:e0242140.
    PubMed     Abstract available


  384. KAY AW, Thivalapill N, Skinner D, Dube GS, et al
    Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    PLoS One. 2020;15:e0243713.
    PubMed     Abstract available


  385. ISLAM MS, Chughtai AA, Nazneen A, Chowdhury KIA, et al
    A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh.
    PLoS One. 2020;15:e0243951.
    PubMed     Abstract available


  386. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    PubMed     Abstract available


    January 2019
  387. NARANG A, Garima K, Porwal S, Bhandekar A, et al
    Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.
    PLoS One. 2019;14:e0223163.
    PubMed     Abstract available


  388. HAMID M, Brooks MB, Madhani F, Ali H, et al
    Risk factors for unsuccessful tuberculosis treatment outcomes in children.
    PLoS One. 2019;14:e0222776.
    PubMed     Abstract available


  389. KU CC, Dodd PJ
    Forecasting the impact of population ageing on tuberculosis incidence.
    PLoS One. 2019;14:e0222937.
    PubMed     Abstract available


  390. RICHOMME C, Courcoul A, Moyen JL, Reveillaud E, et al
    Tuberculosis in the wild boar: Frequentist and Bayesian estimations of diagnostic test parameters when Mycobacterium bovis is present in wild boars but at low prevalence.
    PLoS One. 2019;14:e0222661.
    PubMed     Abstract available


  391. ROSSETTO M, Brand EM, Rodrigues RM, Serrant L, et al
    Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.
    PLoS One. 2019;14:e0209174.
    PubMed     Abstract available


  392. LI Y, Huang H, Dong W, Lan T, et al
    Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
    PLoS One. 2019;14:e0223391.
    PubMed     Abstract available


  393. NYATHI S, Dlodlo RA, Satyanarayana S, Takarinda KC, et al
    Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
    PLoS One. 2019;14:e0223076.
    PubMed     Abstract available


  394. YEKTAKOOSHALI MH, Movahedzadeh F, Foumani AA, Sabati H, et al
    Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223335.
    PubMed     Abstract available


  395. BRAND EM, Rossetto M, Calvo KDS, Winkler GB, et al
    Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases in Porto Alegre, 2009-2013: A retrospective cohort.
    PLoS One. 2019;14:e0222786.
    PubMed     Abstract available


  396. MILLER AP, Malekinejad M, Horvath H, Blodgett JC, et al
    Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.
    PLoS One. 2019;14:e0223077.
    PubMed     Abstract available



  397. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    PubMed     Abstract available


  398. EARLY JV, Mullen S, Parish T
    A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222970.
    PubMed     Abstract available


  399. BOUTON TC, de Vos M, Ragan EJ, White LF, et al
    Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    PLoS One. 2019;14:e0223308.
    PubMed     Abstract available


  400. TAGHIPOUR A, Mosadegh M, Kheirollahzadeh F, Olfatifar M, et al
    Are intestinal helminths playing a positive role in tuberculosis risk? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223722.
    PubMed     Abstract available


  401. MCINTOSH AI, Jenkins HE, Horsburgh CR, Jones-Lopez EC, et al
    Partitioning the risk of tuberculosis transmission in household contact studies.
    PLoS One. 2019;14:e0223966.
    PubMed     Abstract available


  402. MAGHRADZE N, Jugheli L, Borrell S, Tukvadze N, et al
    Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing.
    PLoS One. 2019;14:e0223610.
    PubMed     Abstract available


  403. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0224914.
    PubMed     Abstract available


  404. SUBBARAMAN R, Thomas BE, Sellappan S, Suresh C, et al
    Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
    PLoS One. 2019;14:e0224808.
    PubMed     Abstract available


  405. WOLDEYOHANNES D, Assefa T, Aman R, Tekalegn Y, et al
    Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    PLoS One. 2019;14:e0224025.
    PubMed     Abstract available


  406. REID M, Roberts G, Goosby E, Wesson P, et al
    Monitoring Universal Health Coverage (UHC) in high Tuberculosis burden countries: Tuberculosis mortality an important tracer of UHC service coverage.
    PLoS One. 2019;14:e0223559.
    PubMed     Abstract available



  407. Correction: Forecasting the impact of population ageing on tuberculosis incidence.
    PLoS One. 2019;14:e0224673.
    PubMed     Abstract available


  408. ZHENG Z, Lin J, Lu Z, Su J, et al
    Mortality risk in the population of HIV-positive individuals in Southern China: A cohort study.
    PLoS One. 2019;14:e0210856.
    PubMed     Abstract available


  409. BIRUNGI FM, Graham SM, Uwimana J, Musabimana A, et al
    Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study.
    PLoS One. 2019;14:e0211934.
    PubMed     Abstract available


  410. ASANTE-POKU A, Asare P, Baddoo NA, Forson A, et al
    TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.
    PLoS One. 2019;14:e0211822.
    PubMed     Abstract available


  411. XU J, Wang G, Zhang Y, Zhang G, et al
    An outbreak of tuberculosis in a middle school in Henan, China: Epidemiology and risk factors.
    PLoS One. 2019;14:e0225042.
    PubMed     Abstract available


  412. LOUREIRO RB, Maciel ELN, Caetano R, Peres RL, et al
    Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
    PLoS One. 2019;14:e0225197.
    PubMed     Abstract available


  413. MUSSIE KM, Yimer SA, Manyazewal T, Gradmann C, et al
    Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0224277.
    PubMed     Abstract available


  414. CHADHA VK, Anjinappa SM, Dave P, Rade K, et al
    Sub-national TB prevalence surveys in India, 2006-2012: Results of uniformly conducted data analysis.
    PLoS One. 2019;14:e0212264.
    PubMed     Abstract available


  415. YOSHITAKE N, Omori M, Sugawara M, Akishinonomiya K, et al
    Do health beliefs, personality traits, and interpersonal concerns predict TB prevention behavior among Japanese adults?
    PLoS One. 2019;14:e0211728.
    PubMed     Abstract available


  416. GARCIA PK, Annamalai T, Wang W, Bell RS, et al
    Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.
    PLoS One. 2019;14:e0207733.
    PubMed     Abstract available


  417. VAN GINDERDEUREN E, Bassett J, Hanrahan C, Mutunga L, et al
    Health system barriers to implementation of TB preventive strategies in South African primary care facilities.
    PLoS One. 2019;14:e0212035.
    PubMed     Abstract available


  418. LU Z, Jiang W, Zhang J, Lynn HS, et al
    Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
    PLoS One. 2019;14:e0225361.
    PubMed     Abstract available


  419. BAJEHSON M, Musa BM, Gidado M, Nsa B, et al
    Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    PLoS One. 2019;14:e0225165.
    PubMed     Abstract available


  420. MA X, Mirutse G, Bayray A, Fang M, et al
    Tuberculosis treatment outcome: The case of women in Ethiopia and China, ten-years retrospective cohort study.
    PLoS One. 2019;14:e0219230.
    PubMed     Abstract available


  421. OTCHERE ID, van Tonder AJ, Asante-Poku A, Sanchez-Buso L, et al
    Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana.
    PLoS One. 2019;14:e0209395.
    PubMed     Abstract available


  422. TENLAND E, Pochert A, Krishnan N, Umashankar Rao K, et al
    Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles.
    PLoS One. 2019;14:e0212858.
    PubMed     Abstract available


  423. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    PubMed     Abstract available


  424. VARKILA MRJ, Vos AG, Barth RE, Tempelman HA, et al
    The association between HIV infection and pulmonary function in a rural African population.
    PLoS One. 2019;14:e0210573.
    PubMed     Abstract available


  425. GUPTE AN, Paradkar M, Selvaraju S, Thiruvengadam K, et al
    Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    PLoS One. 2019;14:e0226389.
    PubMed     Abstract available


  426. ALENE KA, Viney K, Moore HC, Wagaw M, et al
    Spatial patterns of tuberculosis and HIV co-infection in Ethiopia.
    PLoS One. 2019;14:e0226127.
    PubMed     Abstract available


  427. SARTORI NS, Picon P, Papke A, Neyeloff JL, et al
    A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment.
    PLoS One. 2019;14:e0224963.
    PubMed     Abstract available


  428. TSEGAYE SAHLE E, Blumenthal J, Jain S, Sun S, et al
    Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners.
    PLoS One. 2019;14:e0226160.
    PubMed     Abstract available


  429. GEBREMICAEL G, Kassa D, Alemayehu Y, Gebreegziaxier A, et al
    Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
    PLoS One. 2019;14:e0226137.
    PubMed     Abstract available


  430. RAJAMANICKAM A, Munisankar S, Dolla CK, Babu S, et al
    Undernutrition is associated with perturbations in T cell-, B cell-, monocyte- and dendritic cell- subsets in latent Mycobacterium tuberculosis infection.
    PLoS One. 2019;14:e0225611.
    PubMed     Abstract available


  431. WU B, Yu Y, Du C, Liu Y, et al
    Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017.
    PLoS One. 2019;14:e0216018.
    PubMed     Abstract available


  432. FATIMA R, Yaqoob A, Qadeer E, Hinderaker SG, et al
    Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children.
    PLoS One. 2019;14:e0227186.
    PubMed     Abstract available


  433. FELLAG M, Loukil A, Saad J, Lepidi H, et al
    Translocation of Mycobacterium tuberculosis after experimental ingestion.
    PLoS One. 2019;14:e0227005.
    PubMed     Abstract available


  434. ABONG J, Dalay V, Langley I, Tomeny E, et al
    Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.
    PLoS One. 2019;14:e0227093.
    PubMed     Abstract available


  435. ORINA F, Mwangi M, Meme H, Kitole B, et al
    Intrinsic and extrinsic factors associated with sputum characteristics of presumed tuberculosis patients.
    PLoS One. 2019;14:e0227107.
    PubMed     Abstract available


  436. CHAVES TORRES NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, et al
    Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.
    PLoS One. 2019;14:e0226507.
    PubMed     Abstract available


  437. ARRIAGA MB, Torres NMC, Araujo NCN, Caldas SCC, et al
    Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    PLoS One. 2019;14:e0227101.
    PubMed     Abstract available


  438. IZUDI J, Tamwesigire IK, Bajunirwe F
    Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis.
    PLoS One. 2019;14:e0226919.
    PubMed     Abstract available


  439. YANG J, Lee S, Oh S, Han S, et al
    The risk of active tuberculosis among individuals living in tuberculosis-affected households in the Republic of Korea, 2015.
    PLoS One. 2019;14:e0225744.
    PubMed     Abstract available


  440. BLANKLEY S, Gashu T, Ahmad B, Belaye AK, et al
    Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe.
    PLoS One. 2019;14:e0214739.
    PubMed     Abstract available


  441. XU C, Li R, Shewade HD, Jeyashree K, et al
    Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    PLoS One. 2019;14:e0214943.
    PubMed     Abstract available


  442. DUNCAN K, Sinanovic E
    A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.
    PLoS One. 2019;14:e0214492.
    PubMed     Abstract available


  443. AGGARWAL AN, Agarwal R, Sehgal IS, Dhooria S, et al
    Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0213728.
    PubMed     Abstract available


  444. SHEWADE HD, Gupta V, Satyanarayana S, Pandey P, et al
    Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
    PLoS One. 2019;14:e0213345.
    PubMed     Abstract available


  445. KANVATIRTH P, Jeeves RE, Bacon J, Besra GS, et al
    Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PLoS One. 2019;14:e0213713.
    PubMed     Abstract available


  446. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.
    PLoS One. 2019;14:e0215991.
    PubMed     Abstract available


  447. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Abstract available


  448. JIN KW, Lee JY, Rhiu S, Choi DG, et al
    Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.
    PLoS One. 2019;14:e0215297.
    PubMed     Abstract available


  449. MOAYEDI-NIA S, Barss L, Oxlade O, Valiquette C, et al
    The mTST - An mHealth approach for training and quality assurance of tuberculin skin test administration and reading.
    PLoS One. 2019;14:e0215240.
    PubMed     Abstract available


  450. WHITE LV, Lee N, Marin FP, Saludar NR, et al
    Performance of alternative measures to body mass index in the assessment of moderate and severe under-nutrition among acutely unwell patients hospitalized in a TB ward in the Philippines: A cross-sectional study.
    PLoS One. 2019;14:e0215968.
    PubMed     Abstract available


  451. CLEMENS DL, Lee BY, Silva A, Dillon BJ, et al
    Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    PLoS One. 2019;14:e0215607.
    PubMed     Abstract available


  452. MEKONNEN D, Derbie A, Abeje A, Shumet A, et al
    Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0215647.
    PubMed     Abstract available


  453. NAJJINGO I, Muttamba W, Kirenga BJ, Nalunjogi J, et al
    Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.
    PLoS One. 2019;14:e0216901.
    PubMed     Abstract available


  454. KARMAKAR M, Rodrigues CHM, Holt KE, Dunstan SJ, et al
    Empirical ways to identify novel Bedaquiline resistance mutations in AtpE.
    PLoS One. 2019;14:e0217169.
    PubMed     Abstract available


  455. ROBERTSON A, Judge J, Wilson GJ, Vernon IJ, et al
    Predicting badger visits to farm yards and making predictions available to farmers.
    PLoS One. 2019;14:e0216953.
    PubMed     Abstract available


  456. MASONOU T, Hokey DA, Lahey T, Halliday A, et al
    CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    PLoS One. 2019;14:e0217091.
    PubMed     Abstract available


  457. DEMITTO FO, Schmaltz CAS, Sant'Anna FM, Arriaga MB, et al
    Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil.
    PLoS One. 2019;14:e0217014.
    PubMed     Abstract available


  458. LEE N, White LV, Marin FP, Saludar NR, et al
    Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study.
    PLoS One. 2019;14:e0218193.
    PubMed     Abstract available


  459. CARRISOZA-URBINA J, Morales-Salinas E, Bedolla-Alva MA, Hernandez-Pando R, et al
    Atypical granuloma formation in Mycobacterium bovis-infected calves.
    PLoS One. 2019;14:e0218547.
    PubMed     Abstract available


  460. QURESHI S, Ahmad K, Fatima P, Hassan RM, et al
    Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
    PLoS One. 2019;14:e0219324.
    PubMed     Abstract available


  461. JENSEN K, Stevens JM, Glass EJ
    Interleukin 10 knock-down in bovine monocyte-derived macrophages has distinct effects during infection with two divergent strains of Mycobacterium bovis.
    PLoS One. 2019;14:e0222437.
    PubMed     Abstract available


  462. HUANG HL, Liu CJ, Lee MR, Cheng MH, et al
    Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients.
    PLoS One. 2019;14:e0222425.
    PubMed     Abstract available


  463. MATHIASEN VD, Eiset AH, Andersen PH, Wejse C, et al
    Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study.
    PLoS One. 2019;14:e0221232.
    PubMed     Abstract available


  464. BENZEKRI NA, Sambou JF, Tamba IT, Diatta JP, et al
    Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: A randomized pilot implementation study.
    PLoS One. 2019;14:e0219118.
    PubMed     Abstract available


  465. DATIKO DG, Habte D, Jerene D, Suarez P, et al
    Knowledge, attitudes, and practices related to TB among the general population of Ethiopia: Findings from a national cross-sectional survey.
    PLoS One. 2019;14:e0224196.
    PubMed     Abstract available


  466. HOMOLKA S, Zallet J, Albert H, Witt AK, et al
    Introduction of quality management in a National Reference Laboratory in Germany.
    PLoS One. 2019;14:e0222925.
    PubMed     Abstract available


  467. KIM TY, Chang HE, Lee SW, Seo SH, et al
    A novel strategy for interpreting the T-SPOT.TB test results read by an ELISPOT plate imager.
    PLoS One. 2019;14:e0222920.
    PubMed     Abstract available


  468. BENJAMIN A, Cavalcante SC, Jamal LF, Arakaki-Sanchez D, et al
    Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    PLoS One. 2019;14:e0221038.
    PubMed     Abstract available


  469. MARAIS F, Kallon II, Dudley LD
    Continuity of care for TB patients at a South African hospital: A qualitative participatory study of the experiences of hospital staff.
    PLoS One. 2019;14:e0222421.
    PubMed     Abstract available


  470. DUFFY FJ, Thompson EG, Scriba TJ, Zak DE, et al
    Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
    PLoS One. 2019;14:e0219322.
    PubMed     Abstract available


  471. GAFFAR SMA, Chisti MJ, Mahfuz M, Ahmed T, et al
    Impact of negative tuberculin skin test on growth among disadvantaged Bangladeshi children.
    PLoS One. 2019;14:e0224752.
    PubMed     Abstract available


  472. LOUKIL A, Bouzid F, Osman DA, Drancourt M, et al
    Decrypting the environmental sources of Mycobacterium canettii by high-throughput biochemical profiling.
    PLoS One. 2019;14:e0222078.
    PubMed     Abstract available


  473. WU CY, Chiu HY, Tsai TF
    The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
    PLoS One. 2019;14:e0225112.
    PubMed     Abstract available


  474. BHERING M, Duarte R, Kritski A
    Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.
    PLoS One. 2019;14:e0218299.
    PubMed     Abstract available


  475. KEBEDE A, Beyene D, Yenew B, Diriba G, et al
    Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia.
    PLoS One. 2019;14:e0225205.
    PubMed     Abstract available


  476. SINGH B, Saqib M, Chakraborty A, Bhaskar S, et al
    Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.
    PLoS One. 2019;14:e0224239.
    PubMed     Abstract available


  477. KENDALL EA, Kamoga C, Kitonsa PJ, Nalutaaya A, et al
    Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    PLoS One. 2019;14:e0220251.
    PubMed     Abstract available


  478. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: